The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Don't know anything about i3e so no idea, but then no one else does either!
Not really. I think from other comments the thoughts are some firm 2p reserves that are close/ready to be developed to put marathon team to good immediate use. Hence iog bid. I don't think explo really their style, too high risk and far away from cash flow gen. They need cash flow from acquisitions pretty quickly to take care of decom etc. Especially if they leverage use of marathons cash balance.
Recent oil dive should also aid sharpening the pencils as am sure they've got eyes/ discussions on further acquisitions.
The large prints will be an order being worked through by brokers, matched by pi's buying or selling multiple small amounts. Assume the new shares that were voted on have now been issued and a pessimistic person would say these are the placing shares now being sold for a quick 20-30% profit to pi's... although an optimistic person would say this is an institution loading up ...but with no sp movement...
You could also open a spreadbet as is tax free...?
I had £12 first slice and then up towards £20 before marathon Rookie, but feel like it's a completely different ball game now. The attempt to go after iog at same time as marathon just illustrates AA is far from finished and cant see him not adding further considerable assets from here, as well as Arran development.
Nope, some interview said 3 months, or h2. I reckon June but could be bit earlier... suspended on 25th Feb.
My magic number is £40 a share, 500mill market cap. Very interested to see new prospectus when revealed, and hopefully many more acquisitions to come so who knows if we can hit that late this year, mid next? I like to think with marathon we're looking at least 300mill market cap so £24 sp in due course, bearing in mind broker targets pre marathon were £14 up to £20+ unrisked. Add in a more reasonable PE and perhaps another acquisition or 2 and I see this as a very reasonable and reachable target, just don't know how long to get there!
Hopefully a new presentation with marathon assets and very clear guidance and graphic of decom costs and strategy to deal with it will be there.....
Plus still have warrants that have just been extended to dilute you 100% again.....
They're back to same price before rre, but with possibly twice as many shares to be in issue....so your holding would be worth half as much if placing goes ahead....
What's hard to understand here. If they get the debt, they will not have to pay nr 20p. They will dilute the crap out of iog and then have control of the company anyway
£40 Is 500m market cap and 500% from last close (approx). I mean id love it obviously but seems too good to be true!
There's A recent rns about 6% ish of future share options. But obviously they haven't been reached yet... also some rns about salary as 1p shares. Not many shares thou and for all we k ow could have already sold them...
Have board holdings changed since Jan 14th then, the log website doesnt show any board ownership? As per previous post, I see the rms giving share options, but obviously they haven't reached the strike price yet?
Rre holder here. Quick question, Why doesn't the board hold much stock? If they dont have much stock then obviously their interest lies in continuing to take a paycheck from iog rather than accept an offer that they wont get a large piece of or am I missing something? I have no idea on the value of iog, just curious over the management interest. Much twiddling of thumbs by us rre holders, we could be locked in for months!
Believe it's marathons cash position. Alot held for decom but still.
Tell me how a stock proceeds to trend to double in price if it not making new 52 weeks highs all the time.
Company estimate is that decom is 20 to 25% of yearly ebitda. Although decom Cost are constantly coming down in the north sea and Whitman broker note expects decom to reduce. They do however highlight even it it rose by 30% it doesn't have a huge edge t on cashflow/ profit. Worth getting that broker note from research tree.
No. Believe it's estimate decom cost of 200 to 250 mill but that's spread out over 5 to 10 years, not sure exact time period. And could be spread out longer if assetts extend life expectancy. Ie bleo holm hoping to be extend up to 2029 depending on upcoming report due.